Janus Henderson Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-5,507
| Closed | -$57.8K | – | 2644 |
|
2023
Q1 | $57.8K | Buy |
5,507
+3,075
| +126% | +$32.3K | ﹤0.01% | 2654 |
|
2022
Q4 | $82.3K | Sell |
2,432
-2,431
| -50% | -$82.2K | ﹤0.01% | 2364 |
|
2022
Q3 | $234K | Buy |
4,863
+2,436
| +100% | +$117K | ﹤0.01% | 2327 |
|
2022
Q2 | $138K | Sell |
2,427
-3
| -0.1% | -$171 | ﹤0.01% | 2413 |
|
2022
Q1 | $196K | Sell |
2,430
-125
| -5% | -$10.1K | ﹤0.01% | 2448 |
|
2021
Q4 | $518K | Buy |
2,555
+764
| +43% | +$155K | ﹤0.01% | 1871 |
|
2021
Q3 | $482K | Buy |
+1,791
| New | +$482K | ﹤0.01% | 1634 |
|
2021
Q2 | – | Sell |
-3,922
| Closed | -$1.18M | – | 1648 |
|
2021
Q1 | $1.18M | Buy |
+3,922
| New | +$1.18M | ﹤0.01% | 1255 |
|
2020
Q4 | – | Sell |
-3,323
| Closed | -$827K | – | 1411 |
|
2020
Q3 | $827K | Sell |
3,323
-923
| -22% | -$230K | ﹤0.01% | 1162 |
|
2020
Q2 | $1.48M | Sell |
4,246
-288
| -6% | -$100K | ﹤0.01% | 1073 |
|
2020
Q1 | $1.21M | Sell |
4,534
-71,285
| -94% | -$19.1M | ﹤0.01% | 1076 |
|
2019
Q4 | $24.5M | Sell |
75,819
-21,391
| -22% | -$6.93M | 0.01% | 775 |
|
2019
Q3 | $26.6M | Sell |
97,210
-65,874
| -40% | -$18M | 0.01% | 760 |
|
2019
Q2 | $87M | Sell |
163,084
-1,107
| -0.7% | -$591K | 0.05% | 416 |
|
2019
Q1 | $82.8M | Sell |
164,191
-4,273
| -3% | -$2.15M | 0.05% | 445 |
|
2018
Q4 | $83.1M | Sell |
168,464
-133,936
| -44% | -$66M | 0.05% | 404 |
|
2018
Q3 | $277M | Sell |
302,400
-23,998
| -7% | -$21.9M | 0.15% | 176 |
|
2018
Q2 | $239M | Sell |
326,398
-25,789
| -7% | -$18.9M | 0.14% | 195 |
|
2018
Q1 | $561M | Buy |
352,187
+98,499
| +39% | +$157M | 0.33% | 67 |
|
2017
Q4 | $227M | Buy |
253,688
+31,736
| +14% | +$28.4M | 0.14% | 192 |
|
2017
Q3 | $79.9M | Buy |
221,952
+103,757
| +88% | +$37.4M | 0.05% | 403 |
|
2017
Q2 | $34.7M | Buy |
+118,195
| New | +$34.7M | 0.02% | 613 |
|